Univerzita PardubiceFakulta chemicko- technologická

Univerzita Pardubice

Zaměstnanci
|
Studenti
English

Publikace detail

Novel potential proteasome inhibitors based on tripeptide scaffold

Autoři: Dušek Jan | Imramovský Aleš

Rok: 2014

Druh publikace: ostatní - přednáška nebo poster

Strana od-do: nestránkováno

Tituly:

Jazyk	Název	Abstrakt	Klíčová slova
eng	Novel potential proteasome inhibitors based on tripeptide scaffold	Inhibition of proteasome via blocking its protein recycling function is one of a very promising ways to treat tumor cells or multiple myeloma. The most perspective inhibitors are carfilzomib (1, approved as Kyprolis®), bortezomib (2, approved as Velcade®) and MG132 (3). The potential inhibitors based on the salicylaic acid and tripeptide scaffold (4, O-benzyl-5-chlorosalicyl-tripeptides) were designed and synthesized. Due to a very similar constitution of mentioned novel compounds it can be expected very similar properties as well as biological activities. Prepared compounds are going to be tested as proteasomal and protein kinase inhibitors for the type of caused apoptosis.